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The protozoan parasite Trypanosoma cruzi circulates in the blood upon infection and 
invades various cells. Parasites intensively multiply during the acute phase of infection 
and persist lifelong at low levels in tissues and blood during the chronic phase. Natural 
killer (NK) and NKT cells play an important role in the immune control of T. cruzi 
infection, mainly by releasing the cytokine IFN-γ that activates the microbicidal action 
of macrophages and other cells and shapes a protective type 1 immune response. 
The mechanisms by which immune cells are regulated to produce IFN-γ during T. cruzi 
infection are still incompletely understood. Here, we show that urokinase plasminogen 
activator (uPA) is induced early upon T. cruzi infection and remains elevated until day 20 
post-infection. We previously demonstrated that the inhibitory receptor Ly49E, which 
is expressed, among others, on NK and NKT cells, is triggered by uPA. Therefore, we 
compared wild type (WT) to Ly49E knockout (KO) mice for their control of experimental 
T. cruzi infection. Our results show that young, i.e., 4- and 6-week-old, Ly49E KO mice 
control the infection better than WT mice, indicated by a lower parasite load and less 
cachexia. The beneficial effect of Ly49E depletion is more obvious in 4-week-old male 
than in female mice and weakens in 8-week-old mice. In young mice, the lower T. cruzi 
parasitemia in Ly49E KO mice is paralleled by higher IFN-γ production compared to 
their WT controls. Our data indicate that Ly49E receptor expression inhibits the immune 
control of T. cruzi infection. This is the first demonstration that the inhibitory Ly49E 
receptor can interfere with the immune response to a pathogen in vivo.
Keywords: ly49e receptor, natural killer cells, Trypanosoma cruzi, immune control, urokinase plasminogen 
activator, iFn-γ
inTrODUcTiOn
Trypanosoma cruzi is an intracellular protozoan parasite infecting 8–10 million people, especially 
in endemic areas of Latin America. American trypanosomiasis, also called Chagas disease, mainly 
results from transmission of parasites from blood-sucking triatomine bugs, leading to a severe 
chronic disease in 30–40% of infected people. Other transmission ways include transfusion of 
contaminated blood, organ transplantation, and the congenital route (1, 2). T. cruzi infection 
Abbreviations: dpi, day post-infection; tPA, tissue plasminogen activator; uPA, urokinase plasminogen activator.
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evolves in two phases: 1) the initial or acute phase, which lasts 
for approximately 10 weeks after infection and is characterized 
by a high number of parasites present in blood and tissues, 
mostly without symptoms though it may be life-threatening, 
particularly in children, and 2) the chronic phase during which 
parasites persist lifelong at very low levels in different tissues. 
This phase is asymptomatic until 30–40% of the individuals 
develop severe cardiac or digestive damages that may be lethal. 
The cardiac form is the most frequent manifestation of chronic 
Chagas disease. It leads to arrhythmia, apical aneurysm, cardiac 
failure, thromboembolism, and sudden death. Parasite persis-
tence and unbalanced type 1 inflammatory immune response 
are likely the dominant determinants of Chagas’ cardiomyopathy. 
Autoantibodies and a hypercoagulability state might also be 
involved (1–3).
Parasites enter the body as metacyclic trypomastigotes 
through broken skin, caused by a bug bite or through other cuts 
and abrasions, or through mucous membranes, including the 
eyes and mouth. T. cruzi trypomastigotes then invade host cells. 
All types of nucleated cells are potential targets. Inside host cells, 
they transform into amastigotes, which multiply by binary fis-
sion in the cytoplasm. They redifferentiate into trypomastigotes 
that are released upon cell rupture and disseminate through the 
bloodstream to infect new cells or are taken up by a triatomine 
bug (4). To invade the host and the susceptible host cells, the para-
site has to pass barriers such as the extracellular matrix thanks to 
surface or secreted proteases degrading the extracellular matrix 
(5, 6). The parasite might also indirectly trigger degradation of the 
extracellular matrix by activating host proteases. One of these is 
plasmin (6), which is produced from plasminogen by the action 
of plasminogen activator (7). To do this, the parasite can bind 
soluble plasminogen to its surface (6, 8). Moreover, production of 
plasminogen activator by macrophages has been shown to occur 
during T. cruzi infection in mice (9). Besides its role in parasite 
invasiveness, components of the plasminogen activation system 
might be involved in chagasic chronic cardiomyopathy. Indeed, 
patients suffering from chagasic chronic cardiomyopathy present 
elevated levels of plasminogen and reduced levels of plasminogen 
activator inhibitor-1 (PAI-1) (10, 11).
Infection of the liver during acute T. cruzi infection has been 
demonstrated both in infected humans and experimentally 
infected mice. This organ is particularly efficient in controlling 
parasite multiplication and harbors low numbers of amastigote 
nests as compared to other organs, although displaying inflam-
mation (12). A major protective cytokine in this process is 
IFN-γ, as acutely infected IFN-γ knockout (KO) mice present 
numerous amastigote nests in the liver in contrast to wild-type 
(WT) mice (12). Liver natural killer (NK) cells have been char-
acterized as rapidly expanding and as early IFN-γ producers. 
As the infection progresses, conventional T cells and γδ T cells 
likely provide the IFN-γ necessary for liver protection against 
T. cruzi infection. Furthermore, Duthie and Kahn (13) have 
shown that both liver NK cells and NKT (including invariant 
NKT) cells provide protection during T. cruzi infection. NKT 
cells express T cell receptors recognizing glycolipids presented 
by the monomorphic MHC class-I-like molecule CD1d. When 
activated, they regulate other immune cells through cell–cell 
interactions and rapid cytokine production (14). Accordingly, 
alpha-galactosylceramide-activated NKT cells secrete IFN-γ, 
which then generally contributes to NK cell activation (15). It 
has been shown that T. cruzi in association with IL-12 activates 
NKT cells early during mouse infection to produce IFN-γ (16). 
However, activation of liver NK cells during T. cruzi infection and 
early protection occurs independently of iNKT cells. In contrast, 
iNKT cells regulate the size of the liver NK cell population, espe-
cially during the first days of infection, thereby likely limiting the 
damaging pro-inflammatory response (17). The protective role of 
NK cells during T. cruzi infection has been further demonstrated 
in NK-depleted mice, which are characterized by higher para-
sitemia and shorter survival time (18–22).
Natural killer cells express a repertoire of activating and 
inhibitory receptors, including Ly49 receptors in mouse. A 
unique member of this family is the inhibitory Ly49E receptor, 
which has characteristics that are clearly distinct from other 
Ly49 family members. Unlike other Ly49 receptors, Ly49E 
does not bind classical MHC-I ligands (23). Instead, Ly49E is 
triggered by urokinase plasminogen activator (uPA) (24). Also, 
Ly49E is the only Ly49 receptor expressed on fetal and neonatal 
NK cells (25, 26), while in adult tissues, Ly49E expression is 
largely restricted to NKT cells, skin Vγ3 T cells, and intestinal 
intraepithelial T lymphocytes (27–29). Conventional peripheral 
NK cells in adult mice have low Ly49E expression levels (25, 
28, 30); however, tissue-resident CD49a+CD49b− liver NK cells 
express high Ly49E levels, and this both in fetal, newborn, and 
adult mice (31).
Natural killer and NKT cells play an important role in the 
control of liver parasite burden during the acute phase of T. cruzi 
infection (12, 13). This, combined with the high expression of 
the inhibitory Ly49E receptor on liver NK and NKT cells (25, 
31), with the induction of macrophages to secrete high levels of 
plasminogen activator upon T. cruzi infection (9), and with the 
triggering of the Ly49E receptor by uPA (24), led us to hypothesize 
that Ly49E plays a regulatory role in T. cruzi infection. We show 
that plasma uPA levels are increased during T. cruzi infection. By 
comparing WT to Ly49E KO mice, we further demonstrate that 
young Ly49E KO mice control the infection better than WT mice 
and this is paralleled by higher IFN-γ production in Ly49E KO 
mice. Thus, Ly49E expression is harmful in the immune control 
of T. cruzi infection.
MaTerials anD MeThODs
animals
Heterozygous Ly49E+/− mice (C57BL/6 background) were 
interbred to obtain homozygous Ly49E+/+ (WT) and Ly49E−/− 
(KO) mice, which were bred separately thereafter (31). Ly49E 
WT and KO mice were bred in individually ventilated cages in 
the SPF animal facility of Ghent University (Ghent, Belgium). 
Mice were sex- and age-matched in each experiment. WT and 
Ly49E KO mice T. cruzi infections were performed at the 
Université Libre de Bruxelles (ULB; Belgium). Animals were 
housed in the accredited animal facility, and animal experi-
mentations were performed after approval by and according 
to the guidelines of the “Université Libre de Bruxelles” Ethic 
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Committee for the use of laboratory animals, adhering to the 
Belgian legislation on protection of such animals (protocol 
529N approved by CEBEA).
Male and female mice at the age of 4–8 weeks were infected 
with T. cruzi blood trypomastigotes and were age matched 
between WT and Ly49E KO mice. Mice were subcutaneously 
(s.c.) inoculated by footpad inoculation of 50 (4-week-old mice) 
or 100 (6- and 8-week-old mice) viable trypomastigotes of the 
Tulahuen strain (genotype VI).
Parasitemia was determined by microscopic examination of 
tail vein blood, with a detection limit of 10,000 parasites/ml, as 
described previously (32). For cytokine and uPA analysis, tail 
vein blood was withdrawn from non-infected animals (either 
before infection or from age-matched mice) and at several 
time points post-infection, as indicated. Blood was collected 
in heparinized capillaries (Hirschmann, Eberstadt, Germany) 
and immediately diluted twofold with buffer containing pro-
tease inhibitors (NaCl 0.15  M with 13  mM Na citrate, 1  mM 
tosyl-l-lysyl-chloromethane hydrochloride, and 1000  KIU/ml 
aprotinin). Subsequently, plasma was obtained upon sample 
centrifugation and stored at −70°C until use. Survival time 
and body weight were regularly recorded during infection. 
Body weight changes were expressed as [(weight on experi-
mental day  −  weight on day of infection)/weight on day of 
infection] ×  100.
cell Preparation and Flow 
cytometric analysis
Spleen and liver lymphocytes were isolated from non-infected 
and T. cruzi-infected WT and Ly49E KO mice that were sac-
rificed by cervical dislocation. Spleens were disrupted, minced, 
and passed through a 40-μm cell strainer (Falcon Franklin Lakes, 
NJ, USA). Erythrocytes were lysed with ammonium– chloride–
potassium (ACK) lysing buffer (Invitrogen Corporation, 
Carlsbad, CA, USA), and cells were washed three times with 
DPBS. After mechanical disruption of the liver, lymphocytes 
were isolated using 37.5% Percoll (GE Healthcare, Barrington, 
IL, USA) density centrifugation. Cells were washed with PBS 
and counted with trypan blue to exclude dead cells. Cells 
were flow cytometrically analyzed for cytokine production. 
Therefore, cells were incubated at 37°C and 5% CO2 for 1  h 
in complete RPMI medium [this refers to RPMI 1640 medium 
supplemented with 10% FCS, 100  U/ml penicillin, 100 μg/ml 
streptomycin, 2 mM glutamine, and 50 μM 2-mercaptoethanol 
(all from Invitrogen Corporation)] supplemented with Brefeldin 
A (Golgiplug, BD Biosciences). Cells were collected, cell-
surface stained, and subsequently permeabilized using Cytofix/
Cytoperm reagent (BD Biosciences, San Jose, CA, USA) and 
intracellularly stained with anti-IFN-γ and anti-TNF-α mAb. 
Lymphocyte subpopulations were gated as follows: NK cells 
(CD3−NK1.1+), NKT cells (CD3dimNK1.1+), CD8+ T cells (CD3+ 
NK1.1−CD8+CD4−), CD4+ T cells (CD3+NK1.1−CD8−CD4+), 
and γδ+ T cells (CD3+NK1.1−TCRδ+). The absolute cell number 
of IFN-γ- and TNF-α-positive cells in each subpopulation was 
calculated based on the total viable cell number, the percent-
age of the representative subpopulation, and the percentage of 
IFN-γ- or TNF-α-positive cells therein.
Monoclonal antibodies used for labeling were anti-NK1.1 
[phycoerythrin (PE)–cyanine-7-conjugated, clone PK136], 
anti-CD3 (pacific blue-conjugated, clone 145-2C11), anti-γδ-
TCR [fluorescein (FITC)-conjugated, clone GL3], anti-CD8α 
(APC-conjugated, clone Lyt-2), TNF-α (PE-conjugated, clone 
MPG-XT22), anti-IFN-γ (PE-conjugated, clone XMG1.2) 
(all from BD Biosciences, San Jose, CA, USA), and anti-CD4 
(peridinin chlorophyll protein cyanine dye 5.5-conjugated, clone 
L3T4, Biolegend). Before staining, the FcR was blocked with anti-
FcγRII/III mAb (unconjugated, clone 2.4G2, kindly provided by 
Dr. J. Unkeless, New York, NY, USA). Live and dead cells were 
discriminated by the LIVE/DEAD® Fixable Aqua Dead Cell Stain 
Kit (Invitrogen Corporation). Samples were measured using a 
BD LSR II flow cytometer and analyzed using FACSDiva 6.1.2 
software (BD Biosciences).
cytokine analysis
Plasma cytokine levels were determined using mouse IFN-γ, 
TNF-α, and IL-12/IL-23p40 Cytometric Bead Array (CBA) flex 
set kits (BD Biosciences, Belgium), following manufacturer’s 
instructions. Briefly, capture beads were mixed and added to the 
unknown samples and serially diluted cytokine standards for 1 h at 
room temperature. Subsequently, PE-labeled detection antibody 
was added to the samples, incubated for 1 h at room temperature 
and washed with wash buffer. Samples were measured on a BD 
LSR II flow cytometer and analyzed by FCAP Array TM Software 
(BD Bioscience) to determine the cytokine concentrations of the 
experimental samples.
Murine uPa enzyme-linked 
immunosorbent assay
The mouse uPA total antigen assay (Innovative research, Novi, 
MI, USA) was used to determine uPA levels in mouse plasma 
samples obtained at the indicated day post-infection (dpi). 
Briefly, samples were added to microtiter plates pre-coated 
with uPA capture antibody. After 30  min of incubation, plates 
were washed, and polyclonal anti-murine uPA primary antibody 
was added. Excess antibody was washed away, and plates were 
incubated with secondary antibody conjugated to horseradish 
peroxidase. Finally, 3,3′,5,5′-tetramethylbenzidine substrate was 
added. Absorbance levels at 450 nm were determined.
statistical analysis
Data were evaluated statistically using Graphpad Prism 
(Graphpad Software, La Jolla, CA, USA). Datasets were analyzed 
using the non-parametric two-tailed Mann–Whitney U-test. 
A p-value ≤0.05 was considered statistically significant.
resUlTs
Urokinase Plasminogen activator levels 
increase during acute T. cruzi infection
Nogueira et al. showed that peritoneal macrophages harvested 
2 or 3 weeks after T. cruzi infection displayed increased plasmi-
nogen activator levels, as analyzed by fibrin degradation in vitro 
(9). Fibrinolysis can be induced by both plasminogen activator 
FigUre 1 | uPa levels are increased during the acute phase of T. cruzi 
infection. (a) uPA plasma levels were determined by ELISA in WT C57Bl/6 
mice of the indicated age. (B) Four-week-old WT C57Bl/6 mice were 
inoculated s.c. with 50 trypomastigotes. uPA plasma levels were determined 
prior to infection (dpi 0) or at dpi 20 and 27. (c) Eight-week-old WT C57Bl/6 
mice were inoculated s.c. with 100 trypomastigotes. uPA plasma levels were 
determined at dpi 0 or at dpi 4, 9, 18, and 25. (a–c) Statistically significant 
differences are indicated with *p ≤ 0.05, **p < 0.01, and ***p < 0.001 
(Mann–Whitney U-test).
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members, i.e., tissue plasminogen activator (tPA) and uPA. Both 
tPA and uPA convert plasminogen into plasmin, which in turn 
degrades fibrin (33). Additionally, uPA can result in proteolysis 
of extracellular matrix components (33). As we previously 
showed that uPA triggers the inhibitory Ly49E receptor (24), we 
first analyzed, in WT male mice, circulating basal uPA levels in 
mice of different age and whether uPA is induced upon T. cruzi 
infection.
Figure 1A (upper panel) shows an age-dependent decrease 
of basal circulating uPA levels in non-infected mice. This has, 
to the best of our knowledge, not been reported previously. 
Indeed, the fibrinolytic pathways are overall studied in elderly 
in relation to risk of thrombosis or in relation to tumor metas-
tasis (34, 35). Nevertheless, it is well-known that the levels of 
various serum proteins are different in early life as compared 
with adults, in relation to particular features of their immune 
system (36). Figures  1B,C show that T. cruzi infection was 
associated with a significant increase of circulating uPA levels. 
In mice infected at the adult age (Figure 1C), uPA circulating 
levels increased as soon as dpi 4 and remained elevated at least 
until dpi 25, when the parasitemia was ascending (cf. Figure 3B 
for the kinetics of parasitemia). We also observed an elevated 
plasma uPA level at dpi 20 in mice infected at a younger age 
(4-week-old – Figure 1B), i.e., also during the ascending phase 
of parasitemia (cf. Figure  2A). This increase seems less sus-
tained than in adults since uPA returned to basal levels at dpi 
27. The reason of this is currently unknown but might relate to 
different maturity of the immune system with age.
T. cruzi infection is Better controlled in 
ly49e KO Mice compared to Their WT 
controls
As Ly49E expression is higher in early life than in adults (26, 
28), we first infected 4-week old mice. We used a low T. cruzi 
inoculum size (50 trypomastigotes) to prevent a high mortality 
rate, since young mice are more susceptible than adults (37). 
The parasitemia levels were higher in WT male (Figure 2A, left 
panel) as compared to WT female mice (Figure 2B, left panel), in 
accordance with the known higher susceptibility of male animals 
(38). Although no difference in mortality rate or survival time 
was observed between mouse groups (data not shown), Ly49E 
KO mice displayed significantly lower parasitemia than WT mice 
during the acute phase of infection, with the largest difference 
seen in male mice. The difference of parasite load between WT 
and Ly49E KO mice was observed rapidly after the parasitemia 
became patent, reaching 7.5-fold higher mean level in WT as 
compared to KO mice at dpi 35 [17.3 ±  5.5 ×  106  parasites/
ml (mean ±  SEM), n =  4 versus 2.3 ±  0.3 ×  106  parasites/ml 
(mean ± SEM), n = 5, p = 0.016 (Mann–Whitney U-test)]. We 
also kinetically analyzed the weight of the mice, since cachexia 
is known to occur during the acute infection (38). As the mice 
were inoculated with T. cruzi at the age of 4 weeks, these mice are 
still in their growing period. Mice of both WT and KO groups 
initially gained weight, though somewhat slower in male WT 
mice (Figures 2A,B, right panels). At the beginning of the patent 
parasitemic phase (dpi 11–14), WT and KO mice underwent 
a similar and transient sharp weight loss. When parasitemia 
became higher (dpi 17 onward) and till the end of the acute 
phase, Ly49E KO mice displayed significantly lower weight loss 
FigUre 2 | T. cruzi infection is better controlled in young ly49e KO mice compared to their WT controls. Four-week-old WT and Ly49E KO male (a) and 
female (B) mice were inoculated s.c. with 50 trypomastigotes at day 0. Blood parasitemia levels were examined microscopically at the indicated time points, as 
indicated in the left panels of (a,B). The change in body weight is shown in the right panels (initial weight at the time of infection is set at 0). Results are expressed 
as Box and Whiskers showing the median from 4 WT and 4 KO male mice and 12 WT and 6 KO female mice. Significant differences between WT and Ly49E KO 
mice are indicated with *p < 0.05 (Mann–Whitney U-test).
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than WT mice. The difference was again more pronounced in 
male mice.
These results indicate that expression of the inhibitory 
Ly49E receptor is harmful in the control of T. cruzi infection of 
young mice.
As mentioned above, the age of the mice is important for the 
resultant parasitemia and for the severity of the disease symptoms 
(37). Moreover, Ly49E expression weakens with age (26, 28). We 
therefore tested whether the harmful effect of the Ly49E receptor 
persisted in older mice. We infected 6- and 8-week-old mice in 
the subsequent experiments, with a slightly higher inoculum 
size (100 trypomastigotes). As expected, infection of 6- and 
8-week-old mice resulted in a trend to lower parasitemia in male 
WT mice [11 ± 1 × 106 parasites/ml (mean ± SEM), n = 12 and 
8 ±  2 ×  106  parasites/ml (mean ±  SEM), n =  10, respectively; 
Figures  3A,B] as compared to 4-week-old male WT mice 
[17 ± 6 × 106 parasites/ml (mean ± SEM), n = 4; cf. Figure 2A], 
though differences did not reach statistical significance [p = 0.127 
(6- versus 4-week-old); p  =  0.057 (8- versus 4-week-old), 
Mann–Whitney U-test]. We still observed in 6-week-old Ly49E 
KO mice a significantly decreased parasitemia compared to WT 
mice (Figure 3A). This was associated with a trend in less weight 
loss of the infected Ly49E KO mice as compared to WT mice, 
which was significantly different at dpi 18 (Figure 3A). However, 
in 8-week-old mice, there were no more significant differences in 
parasitemia between WT and Ly49E KO mice (Figures 3B,C), 
though we observed a trend of lower parasitemia in Ly49E KO 
male mice (Figure 3B), as well as a trend for lower weight loss 
FigUre 3 | The harmful effect of the ly49e receptor on the course of T. cruzi infection weakens with mouse age. WT and Ly49E KO were inoculated 
s.c. with 100 trypomastigotes at day 0 at the age of 6 (a) or 8 weeks (B,c). Blood parasitemia levels were determined at the indicated time points (left panels). 
Right panels – body weight changes at the indicated days after infection, relative to the initial weight at the time of infection. Results are expressed as Box and 
Whiskers showing the median from 14 WT and 14 KO 6-week-old mice (a), 5 WT and 5 KO 8-week-old male mice (B) and 5 WT and 5 KO 8-week-old female 
mice (c). Statistically significant differences between WT and Ly49E KO mice are indicated with *p ≤ 0.05 and **p < 0.01 (Mann–Whitney U-test).
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in Ly49E KO mice compared to WT controls in both female and 
male mice (Figures  3B,C). The mortality rates were similar in 
WT and Ly49E KO mice, and this in both experiments (8- and 
6-week-old mice) (data not shown).
These results show that the harmful effect of Ly49E receptor 
expression on T. cruzi infection weakens with age.
T. cruzi-infected ly49e KO Mice 
Produce higher levels of iFn-γ
IFN-γ is the most important cytokine for the control of T. cruzi 
infection (39). Since Ly49E has been shown to inhibit IFN-γ 
production by cells bearing this receptor (24), we investigated 
the production of this cytokine, as well as IL-12p40 and TNF-
α, in T. cruzi-infected Ly49E KO versus WT male mice. We 
analyzed plasma samples from 4-week-old mice at 20 or 27 days 
post-infection of T. cruzi trypomastigotes or from age-matched 
non-infected mice. In parallel, parasitemia was analyzed.
Both at dpi 21 and dpi 28, parasite blood levels in Ly49E KO 
were reduced as compared to WT animals (Figure 4A), confirm-
ing the harmful effect of the Ly49E receptor on the control of 
infection (cf. Figure 2A). All tested cytokines were increased in 
the circulation of infected mice compared to non-infected mice 
at both examined time points (Figure  4B). TNF-α levels were 
elevated most (Figure 4B, left panel), but there was no significant 
difference between WT and Ly49E KO mice. There was also no 
significant difference for IL-12 p40 in infected WT versus Ly49E 
KO mice (Figure 4B, right panel). However, for IFN-γ, there was 
a trend in lower levels in WT compared to Ly49E KO mice at dpi 
20, and this became a statistically significant difference at dpi 27 
(Figure 4B, middle panel).
We euthanized the mice at dpi 27, i.e., near the peak of 
parasitemia, and measured ex vivo cytokine production in several 
immune subpopulations of spleen and liver by flow cytometric 
analysis (Figure 4C). At this time point, CD4+ T cells were the 
main source of IFN-γ in the spleen as well as in the liver of 
WT-infected mice. CD8+ T cells also contributed in the spleen, 
but not in the liver, while NK and NKT cells did not measurably 
produce IFN-γ neither in the spleen nor in the liver. By contrast, 
infected Ly49E KO mice displayed heightened IFN-γ production 
by CD4+ and CD8+ T cells but also their NK and NKT cells 
produced IFN-γ, with NKT cells becoming the main IFN-γ-
producing cells in the liver. TNF-α production was also mainly 
observed in spleen CD4+ and CD8+ T cells with no difference 
in infected WT as compared to Ly49E KO mice. The situation is 
different in the liver where TNF-α was mainly produced by NKT 
and NK cells, again without difference between mouse groups.
These results show that the protective cytokine IFN-γ is pro-
duced less in Ly49E-expressing mice.
DiscUssiOn
The key role of IFN-γ in the control of T. cruzi infection has been 
acknowledged since a long time (39). This cytokine is produced 
by NKT and NK cells early during infection, followed by CD4+ 
and CD8+ T cells when the adaptive immune response develops 
(12, 13, 18, 20, 21, 40). The protective effect of IFN-γ mainly 
relies on activation of macrophages and other cells to limit T. 
cruzi replication during the acute phase of infection (40). IFN-γ 
produced early by NK cells is also important to orchestrate the 
ongoing adaptive immune response, contributing to differentia-
tion of CD4+ Th1 and CD8+ T cells required for the control of 
the parasite multiplication occurring during the acute infection.
Since we have previously shown that the inhibitory Ly49E 
receptor regulates IFN-γ production (24), we explored the role 
of this receptor in the control of T. cruzi infection by comparing 
WT to Ly49E KO mice. Contrary to the other inhibitory Ly49 
receptors that bind MHC-I molecules (23), Ly49E is triggered 
by uPA (a plasminogen activator), resulting in inhibition of 
IFN-γ production (24). Others have shown that plasminogen 
activator is produced by macrophages upon T. cruzi infection 
(9). We confirmed and extended these results in the present 
study by showing that plasma uPA levels are increased in T. 
cruzi-infected mice. Of note, uPA levels increased early during 
the infection, i.e., during the pre-patent and the ascending phases 
of the parasitemia. This might reflect macrophage activation (9). 
Contrary to 8-week-old mice, in which plasma uPA levels are 
still increased at dpi 25, infected 4-week-old mice display basal 
plasma uPA levels at dpi 27, when parasitemia is high. We can 
only speculate on the reason for this. First, if uPA initially would 
promote parasite invasion by triggering plasminogen activation 
and degradation of extracellular matrix, it has no more sense 
to maintain increased levels when parasite load is so high and 
life-threatening for the host. Second, uPA is produced in several 
cell types, including not only epithelial and endothelial cells 
but also immune cells. Neutrophils and macrophages are the 
major uPA-producing immune cell populations. Production of 
plasminogen activator by macrophages has been shown to occur 
during T. cruzi infection in the mouse (9). uPA-producing cells 
might become refractory during later stages of T. cruzi infection 
in young mice, resulting in less uPA production when parasitemia 
is highest. Third, whereas plasma uPA levels are returned to 
basal levels at later stages of infection in 4-week-old mice, local 
uPA concentrations in blood vessels of infected tissues might 
still be increased as also endothelial cells produce uPA during 
infection. This is of particular interest as CD49b− liver NK cells, 
the subpopulation of NK cells that mainly expresses Ly49E, are 
tissue-resident cells that reside in the hepatic sinusoids.
We showed that particularly at young age, i.e., 4–6 weeks after 
birth, Ly49E KO mice displayed lower T. cruzi parasitemia as 
compared to WT mice. Meanwhile, Ly49E KO mice harbored 
higher numbers of IFN-γ-positive NKT, CD4 T cells, and CD8 T 
cells than WT mice near the peak of parasitemia. This was also 
reflected at the systemic level by a slight increase of circulating 
IFN-γ levels in Ly49E KO mice at that time point. Since IFN-γ 
is well-known to be the key cytokine controlling T. cruzi infec-
tion, such higher IFN-γ production in Ly49E KO is probably 
at the origin of the lower parasitemia observed in these mice. 
Our observation that the levels of IL-12, the canonical cytokine 
inducing IFN-γ, were likely not modified in Ly49E KO mice as 
compared to WT animals (though levels of bioactive IL-12p70 
should be verified), suggests that the higher IFN-γ expression in 
Ly49E KO mice might be IL-12 independent. This argues for a 
direct role of the Ly49E receptor on the global IFN-γ response.
FigUre 4 | enhanced iFn-γ production in T. cruzi-infected ly49e KO mice compared to their WT controls. Four-week-old male WT and Ly49E KO 
mice were inoculated s.c. with 50 trypomastigotes at day 0. (a) Blood parasitemia levels are shown at the indicated time points (WT, n = 24; Ly49E KO, n = 24). 
(B) Plasma levels of the indicated cytokines were determined in non-infected mice (WT, n = 3; Ly49E KO, n = 3) and at day 20 (WT, n = 24; Ly49E KO, n = 24) and 
day 27 post-infection (WT, n = 21; Ly49E KO, n = 21). (c) Intracellular IFN-γ and TNF-α were determined by flow cytometry at day 27 post-infection (WT, n = 6; 
Ly49E KO, n = 6). The results are presented as the absolute cell number of IFN-γ- (left panels) and TNF-α-positive cells (right panels) in the indicated lymphocyte 
subpopulations in either spleen (upper panels) or liver (lower panels). Statistical analysis was performed using the Mann–Whitney U-test (*p < 0.05 and **p < 0.01).
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We investigated in male Ly49E KO mice infected when they 
were 4-week old, the liver and splenic immune responses at day 
27 post T. cruzi infection, i.e., when the inhibition of infection 
in Ly49E KO mice was more pronounced as compared to WT 
animals. At this time, Ly49E KO-infected mice harbored a higher 
proportion of IFN-γ-positive cells than WT-infected animals, 
with the principal IFN-γ producers being CD4+ and CD8+ T 
cells, to a lesser extent NKT cells, whereas NK cells produced 
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hardly IFN-γ. It has a slight systemic impact on circulating IFN-γ 
levels. These data support that IFN-γ production is inhibited in 
WT mice expressing the inhibitory Ly49E receptor and not in 
Ly49E KO mice.
Our current data do not allow to determine if the reduced 
IFN-γ response of liver and spleen NKT and T cells observed in 
4-week-old WT animals at dpi 27 results from a direct inhibition 
through engagement of Ly49E on these cells at this time point, or 
indirectly reflects an inhibition that has occurred earlier during 
infection. Direct inhibition, at this time point, seems less likely 
since the Ly49E ligand (uPA) has returned to normal levels. 
Additionally, the fact that the Ly49E receptor is preferentially 
expressed by NK and NKT cells in younger mice and is also 
expressed at higher levels on a per cell basis in these mice [(31) 
and data not shown], also argues for an indirect effect of earlier 
inhibition of IFN-γ production. Our hypothesis is that the Ly49E 
receptor is engaged by uPA early during infection, probably as 
soon as uPA levels are increased, and with a more pronounced 
effect in young mice harboring a higher proportion of Ly49E+ 
NK cells in the liver than adult mice. What we observe at dpi 27 
might be the consequence of earlier Ly49E engagement on NK 
cells, independently of the present uPA levels that have returned 
to normal levels. This hypothesis is also supported by the fact that 
NK cells are rapidly activated during the first days of infection. 
Indeed, macrophages are among the first cell populations to be 
infected, resulting in IL-12 release (12). This rapidly activates 
NK cells to produce IFN-γ, resulting in a Th1 type response of 
conventional T cells (41–43), necessary for protection against 
T. cruzi infection (12).
Importantly, the beneficial effect of Ly49E deletion was more 
pronounced in young mice than in adult ones. This likely reflects 
the variation in Ly49E expression with the mouse age. Indeed, 
Ly49E is the only Ly49 receptor expressed on neonatal NK cells 
and is largely absent on conventional peripheral NK cells in adult 
mice (25, 26), with the exception of CD49b− liver NK cells that 
express high levels of Ly49E both in newborns and adult mice 
(31). This latter observation might explain the slight effect that 
we still observe in 8-week-old mice.
Ly49E KO mice also displayed reduced cachexia during 
acute T. cruzi infection as compared to WT animals. This is in 
accordance with the relation of weight loss to the parasite burden 
that we previously showed (38). However, we also showed that 
TNF-α produced in high amounts during acute T. cruzi infec-
tion, and not IFN-γ, plays an important role in the cachexia (38). 
Yet, we did not observe different TNF-α levels between Ly49E 
KO and WT mice. Nevertheless, the harmful effect of TNF-α on 
animal weight may rather be regulated by its soluble receptors 
(44), which we have not measured in this study. Besides, our 
observations support a differential regulation of IFN-γ and TNF-
α production by Ly49E-bearing cells. This is not really surprising 
since expression of these cytokines is mostly regulated by dif-
ferent transcription factors and post-translational mechanisms 
(45, 46), but highlights the specific inhibitory action of Ly49E on 
IFN-γ production.
Our data disclose a modulating role for the inhibitory Ly49E 
receptor in the control of an infectious disease, wherein Ly49E 
expression has a deleterious effect for the host regarding its 
ability to control the T. cruzi infection, particularly in young 
hosts. Keeping this in mind, it is, however, puzzling that Ly49E 
expressions and plasma uPA levels are higher in early life, a period 
characterized by increased susceptibility to a lot of infectious 
diseases, mainly due to the difficulty to mount an optimal type 
1 immune response (47). We may hypothesize that the higher 
expression of the inhibitory Ly49E receptor in early life is neces-
sary to limit damaging inflammation that may occur in response 
to infections or, particularly in the liver, easily exposed to various 
microbial products such as endotoxin deriving from the gut (48, 
49), and mostly just after birth due to the sudden colonization by 
microbiota.
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